{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T10:08:19Z","timestamp":1764842899396},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,26]]},"DOI":"10.7759\/cureus.65441","type":"journal-article","created":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T16:27:16Z","timestamp":1722011236000},"source":"Crossref","is-referenced-by-count":1,"title":["The Impact of Anemia on the Survival of Patients Diagnosed With Low-Grade Malignant B-cell Lymphomas"],"prefix":"10.7759","author":[{"given":"Lidia-Maria","family":"Mondoc","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina-Camelia","family":"Catana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liiana-Carmen","family":"Prodan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madalina","family":"Valeanu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romeo-Gabriel","family":"Mihaila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1053\/ctrv.2000.0181","article-title":"Anaemia in cancer: pathophysiology and treatment","volume":"26","author":"Mercadante S","year":"2000","unstructured":"Mercadante S, Gebbia V, Marrazzo A, Filosto S. Anaemia in cancer: pathophysiology and treatment. Cancer Treat Rev. 2000, 26:303-11. 10.1053\/ctrv.2000.0181","journal-title":"Cancer Treat Rev"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.12669\/pjms.35.1.91","article-title":"Frequency and causes of anemia in Lymphoma patients","volume":"35","author":"Yasmeen T","year":"2019","unstructured":"Yasmeen T, Ali J, Khan K, Siddiqui N. Frequency and causes of anemia in Lymphoma patients. Pak J Med Sci. 2019, 35:61-5. 10.12669\/pjms.35.1.91","journal-title":"Pak J Med Sci"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1977.tb00628.x","article-title":"The anaemia of chronic disorders: studies of iron reutilization in the anaemia of experimental malignancy and chronic inflammation","volume":"35","author":"Zarrabi MH","year":"1977","unstructured":"Zarrabi MH, Lysik R, DiStefano J, Zucker S. The anaemia of chronic disorders: studies of iron reutilization in the anaemia of experimental malignancy and chronic inflammation. Br J Haematol. 1977, 35:647-58. 10.1111\/j.1365-2141.1977.tb00628.x","journal-title":"Br J Haematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1007\/s00508-015-0842-3","article-title":"Iron metabolism and iron supplementation in cancer patients","volume":"127","author":"Ludwig H","year":"2015","unstructured":"Ludwig H, Evstatiev R, Kornek G, et al.. Iron metabolism and iron supplementation in cancer patients. Wien Klin Wochenschr. 2015, 127:907-19. 10.1007\/s00508-015-0842-3","journal-title":"Wien Klin Wochenschr"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199006143222401","article-title":"Decreased erythropoietin response in patients with the anemia of cancer","volume":"322","author":"Miller CB","year":"1990","unstructured":"Miller CB, Jones RJ, Piantadosi S, Abeloff MD, Spivak JL. Decreased erythropoietin response in patients with the anemia of cancer. N Engl J Med. 1990, 322:1689-92. 10.1056\/NEJM199006143222401","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.802314","article-title":"Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin","volume":"55","author":"Tisi MC","year":"2014","unstructured":"Tisi MC, Bozzoli V, Giachelia M, et al.. Anemia in diffuse large B-cell non-Hodgkin lymphoma: the role of interleukin-6, hepcidin and erythropoietin. Leuk Lymphoma. 2014, 55:270-5. 10.3109\/10428194.2013.802314","journal-title":"Leuk Lymphoma"},{"key":"ref7","article-title":"Serum levels of interleukin-6 and interleukin-10 in Turkish patients with aggressive non-Hodgkin's lymphoma","volume":"10","author":"Guney N","year":"2009","unstructured":"Guney N, Soydinc HO, Basaran M, et al.. Serum levels of interleukin-6 and interleukin-10 in Turkish patients with aggressive non-Hodgkin's lymphoma. Asian Pac J Cancer Prev. 2009, 10:669-74.","journal-title":"Asian Pac J Cancer Prev"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.1182\/blood.V74.1.130.130","article-title":"Chronic exposure to tumor necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice","volume":"74","author":"Johnson RA","year":"1989","unstructured":"Johnson RA, Waddelow TA, Caro J, Oliff A, Roodman GD. Chronic exposure to tumor necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice. Blood. 1989, 74:130-8.","journal-title":"Blood"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/s0093-7754(01)90205-2","article-title":"Biological basis of anemia","volume":"28","author":"Bron D","year":"2001","unstructured":"Bron D, Meuleman N, Mascaux C. Biological basis of anemia. Semin Oncol. 2001, 28:1-6. 10.1016\/s0093-7754(01)90205-2","journal-title":"Semin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1159\/000354194","article-title":"Impact of interleukin-6 in hematological malignancies","volume":"40","author":"Burger R","year":"2013","unstructured":"Burger R. Impact of interleukin-6 in hematological malignancies. Transfus Med Hemother. 2013, 40:336-43. 10.1159\/000354194","journal-title":"Transfus Med Hemother"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-0348-0837-8_12","article-title":"The role of inflammation in lymphoma","volume":"816","author":"Carbone A","year":"2014","unstructured":"Carbone A, Tripodo C, Carlo-Stella C, Santoro A, Gloghini A. The role of inflammation in lymphoma. Adv Exp Med Biol. 2014, 816:315-33. 10.1007\/978-3-0348-0837-8_12","journal-title":"Adv Exp Med Biol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.6873","article-title":"Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin","volume":"28","author":"Hohaus S","year":"2010","unstructured":"Hohaus S, Massini G, Giachelia M, et al.. Anemia in Hodgkin's lymphoma: the role of interleukin-6 and hepcidin. J Clin Oncol. 2010, 28:2538-43. 10.1200\/JCO.2009.27.6873","journal-title":"J Clin Oncol"},{"key":"ref13","article-title":"Prevalence and aetiology of anaemia in lymphoid malignancies","volume":"26","author":"Ghosh J","year":"2013","unstructured":"Ghosh J, Singh RK, Saxena R, et al.. Prevalence and aetiology of anaemia in lymphoid malignancies. Natl Med J India. 2013, 26:79-81.","journal-title":"Natl Med J India"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1080\/028418698430278","article-title":"Tumor hypoxia and gene expression--implications for malignant progression and therapy","volume":"37","author":"Sutherland RM","year":"1998","unstructured":"Sutherland RM. Tumor hypoxia and gene expression--implications for malignant progression and therapy. Acta Oncol. 1998, 37:567-74. 10.1080\/028418698430278","journal-title":"Acta Oncol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/93.4.266","article-title":"Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects","volume":"93","author":"H\u00f6ckel M","year":"2001","unstructured":"H\u00f6ckel M, Vaupel P. Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst. 2001, 93:266-76. 10.1093\/jnci\/93.4.266","journal-title":"J Natl Cancer Inst"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/s0093-7754(01)90210-6","article-title":"Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy","volume":"28","author":"Vaupel P","year":"2001","unstructured":"Vaupel P, Kelleher DK, H\u00f6ckel M. Oxygen status of malignant tumors: pathogenesis of hypoxia and significance for tumor therapy. Semin Oncol. 2001, 28:29-35. 10.1016\/s0093-7754(01)90210-6","journal-title":"Semin Oncol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12529","article-title":"The significance of pretreatment anemia in the era of R-IPI and NCCN-IPI prognostic risk assessment tools: a dual-center study in diffuse large B-cell lymphoma patients","volume":"95","author":"Troppan KT","year":"2015","unstructured":"Troppan KT, Melchardt T, Deutsch A, et al.. The significance of pretreatment anemia in the era of R-IPI and NCCN-IPI prognostic risk assessment tools: a dual-center study in diffuse large B-cell lymphoma patients. Eur J Haematol. 2015, 95:538-44. 10.1111\/ejh.12529","journal-title":"Eur J Haematol"},{"key":"ref18","article-title":"Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review","volume":"91","author":"Caro JJ","year":"2001","unstructured":"Caro JJ, Salas M, Ward A, Goss G. Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer. 2001, 91:2214-21.","journal-title":"Cancer"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-01-643569","article-title":"The 2016 revision of the World Health Organization classification of lymphoid neoplasms","volume":"127","author":"Swerdlow SH","year":"2016","unstructured":"Swerdlow SH, Campo E, Pileri SA, et al.. The 2016 revision of the World Health Organization classification of lymphoid neoplasms. Blood. 2016, 127:2375-90. 10.1182\/blood-2016-01-643569","journal-title":"Blood"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3978\/j.issn.2304-3865.2012.10.01","article-title":"Clinical practice guidelines on cancer-related anemia (2012-2013 Edition)","volume":"1","year":"2012","unstructured":"Clinical practice guidelines on cancer-related anemia (2012-2013 Edition). Chin Clin Oncol. 2012, 1.18. 10.3978\/j.issn.2304-3865.2012.10.01","journal-title":"Chin Clin Oncol"},{"key":"ref21","unstructured":"Cancer stat facts. non-Hodgkin lymphoma. https:\/\/seer.cancer.gov\/statfacts\/html\/nhl.html."},{"key":"ref22","article-title":"Non Hodgkin's lymphoma - a study","volume":"35","author":"Bukhari U","year":"2015","unstructured":"Bukhari U, Jamal S, Lateef F. Non Hodgkin's lymphoma - a study. Pak Oral Dent J. 2015, 35:412-5.","journal-title":"Pak Oral Dent J"},{"key":"ref23","article-title":"Epidemiology of non-Hodgkin lymphoma: global patterns of incidence, mortality, and trends","volume":"140 Suppl 1","author":"Sedeta E","year":"2022","unstructured":"Sedeta E, Ilerhunmwuwa N, Wasifuddin M, et al.. Epidemiology of non-Hodgkin lymphoma: global patterns of incidence, mortality, and trends. Blood. 2022, 140 Suppl 1:5234-5.","journal-title":"Blood"},{"key":"ref24","article-title":"Burden of anaemia and its impact on lymphoma patients in southern Rajasthan, India: a cross-sectional study","volume":"17","author":"Mukhiya GK","year":"2023","unstructured":"Mukhiya GK, Mukhiya GW, Patel P, Pokar R, Patel A, Thaiyam D, Mukhiya K. Burden of anaemia and its impact on lymphoma patients in southern Rajasthan, India: a cross-sectional study. J Clin Diagn Res. 2023, 17:EC12-7.","journal-title":"J Clin Diagn Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1023\/a:1008498705032","article-title":"Frequency and significance of anemia in non-Hodgkin's lymphoma patients","volume":"9","author":"Moullet I","year":"1998","unstructured":"Moullet I, Salles G, Ketterer N, et al.. Frequency and significance of anemia in non-Hodgkin's lymphoma patients. Ann Oncol. 1998, 9:1109-15. 10.1023\/a:1008498705032","journal-title":"Ann Oncol"},{"key":"ref26","doi-asserted-by":"crossref","DOI":"10.31557\/apjcb.2021.6.4.235-241","article-title":"Anemia in lymphoma patients in Indonesia: the prevalence and predictive factors","volume":"6","author":"Hardianti MS","year":"2021","unstructured":"Hardianti MS, Rizki SH, Arkananda H, et al.. Anemia in lymphoma patients in Indonesia: the prevalence and predictive factors. Asian Pac J Cancer Biol. 2021, 6:235-41.","journal-title":"Asian Pac J Cancer Biol"},{"key":"ref27","doi-asserted-by":"crossref","DOI":"10.4274\/BMJ.galenos.2023.2022.5-12","article-title":"Prevalence and prognostic significance of anemia in lymphoma","volume":"20","author":"Sincan G","year":"2024","unstructured":"Sincan G, K\u0131l\u0131\u00e7 AF, Sincan S, Erdem F. Prevalence and prognostic significance of anemia in lymphoma. Med J Bakirkoy. 2024, 20:42-7.","journal-title":"Med J Bakirkoy"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/271701-the-impact-of-anemia-on-the-survival-of-patients-diagnosed-with-low-grade-malignant-b-cell-lymphomas","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T16:27:25Z","timestamp":1722011245000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/271701-the-impact-of-anemia-on-the-survival-of-patients-diagnosed-with-low-grade-malignant-b-cell-lymphomas"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,26]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.65441","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,26]]}}}